An Open-Label, Multi-Center Study Evaluating the Validity, Reliability, and Responsiveness of a New Women's Ischemia Symptom Questionnaire in Women with Chronic Angina Treated with Ranolazine Extended-Release Tablets

Grants and Contracts Details

StatusFinished
Effective start/end date6/9/099/30/10

Funding

  • Gilead Palo Alto Inc: $7,500.00